Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | HPQ | Common Stock | 16.1K | Nov 1, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | HPQ | Restricted Stock Units | Nov 1, 2024 | Common Stock | 53.4K | Direct | F1, F2 | |||||||
holding | HPQ | Restricted Stock Units | Nov 1, 2024 | Common Stock | 33.4K | Direct | F2, F3 |
Id | Content |
---|---|
F1 | On 10/27/2023, the reporting person was granted 77,399 restricted stock units ("RSUs"), 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 3 includes 1,767 dividend equivalent units. |
F2 | Each RSU represents a contingent right to receive one share of HP common stock. |
F3 | On 12/7/2023, the reporting person was granted 32,302 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 3 includes 1,106.3934 dividend equivalent units. |